Secondly, because insulin is not required it is plausible that harnessing these molecular mechanisms could represent an ideal avenue to improve both types of diabetes; the insulin-deficient type 1 (T1DM) and the insulin-resistant type 2 diabetes mellitus (T2DM). Here, INS is linked to diabetes mellitus.